biblio
“Selective targeting of integrin alpha v beta 8 by a highly active cyclic peptide”, Journal of Medicinal Chemistry, vol. 62, no. 4, pp. 2024-2037, 2019.
, “Overcoming the lack of oral availability of cyclic hexapeptides: design of a selective and orally available ligand for the integrin alpha v beta 3”, Angewandte Chemie-International Edition, vol. 56, no. 51, pp. 16405-16409, 2017.
, “Novel cilengitide-based cyclic RGD peptides as alpha nu beta(3) integrin inhibitors”, Bioorganic & Medicinal Chemistry Letters, vol. 30, no. 8, p. 127039, 2020.
, “N-Methylation of isoDGR peptides: discovery of a selective alpha 5 beta 1-integrin ligand as a potent tumor imaging agent”, Journal of Medicinal Chemistry, vol. 61, no. 6, pp. 2490-2499, 2018.
, “From a helix to a small cycle: metadynamics-inspired alpha v beta 6 integrin selective ligands”, Angewandte Chemie-International Edition, vol. 57, no. 44, pp. 14645-14649, 2018.
,